Prognostic relevance of CD69 expression in B cell chronic lymphocytic leukemia

S Aref, N El Menshawy, MS El-Ghonemy… - Comparative Clinical …, 2019 - Springer
This study aimed to determine the prognostic impact of CD69 expression in B cell chronic
lymphocytic leukemia (CLL). The study included 153 B cell chronic lymphocytic leukemia (B …

[HTML][HTML] Atypical chronic lymphocytic leukemia with CD200 expression shares similar outcomes to classical chronic lymphocytic leukemia

Z Mongeau-Marceau, S Cohen, L Mollica, R LeBlanc… - Blood, 2016 - Elsevier
Introduction Chronic lymphocytic leukemia (CLL) diagnosis relies on a characteristic
immunophenotype of B-cell lymphocytes. The modified Matutes scoring system is based on …

[HTML][HTML] A CD21 low phenotype, with no evidence of autoantibodies to complement proteins, is consistent with a poor prognosis in CLL

EM Nichols, R Jones, R Watson, CJ Pepper, C Fegan… - Oncotarget, 2015 - ncbi.nlm.nih.gov
B-cell chronic lymphocytic leukemia (CLL) is characterized by differential BCR signaling and
autoimmune complications. Complement modulates B-cell function via C3d and CD21 cross …

CD49d and CD26 are independent prognostic markers for disease progression in patients with chronic lymphocytic leukemia

L Ibrahem, WE Elderiny, L Elhelw, M Ismail - Blood Cells, Molecules, and …, 2015 - Elsevier
CLL is characterized by extremely variable clinical course. Several prognostic factors can
predict disease progression and therapeutic outcomes in those patients. The aim was to …

Flow Cytometric Expression of CD49d in Newly Diagnosed Chronic Lymphocytic Leukemia and Its Correlation with Established Prognostic Markers

A Kunnumbrath, N Singh, AK Gupta… - Journal of …, 2022 - thieme-connect.com
Introduction Chronic lymphocytic leukemia (CLL) is the commonest hematological
malignancy in the West but is relatively uncommon in India. The prognosis of CLL is …

Study of the immunological markers CD49d and CD38 in early-stage B-CLL patients

V Popova, S Blazheva, T Lukanov… - Journal of IMAB …, 2018 - journal-imab-bg.org
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of B-lymphocytes
into the blood stream, primary and secondary lymphoid organs as a consequence of defect …

A particular expression pattern of CD13 epitope 7H5 in chronic lymphocytic leukaemia–a possible new therapeutic target

ML Guenova, A Michova, GN Balatzenko, DY Yosifov… - …, 2012 - Taylor & Francis
A total of 50 patients with chronic lymphocytic leukaemia (CLL), as well as the B-cell
leukaemia cell lines MEC-1, JVM-3, and BV-173 were studied in order to assess the …

[HTML][HTML] Impact of CD39 expression on CD4+ T lymphocytes and 6q deletion on outcome of patients with chronic lymphocytic leukemia

EM Zaki, AM Zahran, AA Metwaly, R Hafez… - … /oncology and stem cell …, 2019 - Elsevier
Abstract Objective/Background Chronic lymphocytic leukemia is one of the commonest
leukemias affecting adults. CD39 inhibits T-cell and Natural killer (NK) cell responses by …

[PDF][PDF] Cd49d as prognostic marker in b-cell chronic lymphocytic leukemia in correlation with the expression of cd38, zap-70 and clinical Binet stage

HA Al-Rubaie, ZA Thabit, AM Jawad - Iraqi Postgrad Med J, 2016 - iasj.net
CD49d as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia in Correlation with the
Expression of CD38, ZAP-70 and Clinica Page 1 THE IRAQI POSTGRADUATE MEDICAL …

[HTML][HTML] CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia

D Rossi, A Zucchetto, FM Rossi, D Capello… - …, 2008 - haematologica.org
Identification of prognosticators for Binet A chronic lymphocytic leukemia is important for
selecting patients with dismal prognosis. We analyzed CD49d expression in 140 …